Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Cash Flow Conversion Efficiency
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS cash flow conversion efficiency. Based on the latest financial reports, Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL174.79 Million ≈ $3.91 Million USD) by net assets (TL9.76 Billion ≈ $218.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Gen Ilac ve Saglik Urunleri Sanayi ve Ti (GENIL) market capitalisation for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (2018–2024)
Cash flow conversion efficiency of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS from 2018 to 2024. This chart illustrates how Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View GENIL stock price and chart for real-time trading data and today's change.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Cash Flow Conversion Ratio Explained
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS ranked by their cash flow conversion efficiency. Review free cash flow generation of Gen Ilac ve Saglik Urunleri Sanayi ve Ti to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shen Zhen Australis Electronic Technology Co.Ltd.
SHE:300940
|
0.035x |
|
Unimot S.A
WAR:UNT
|
-0.064x |
|
Plasson Indus
TA:PLSN
|
0.068x |
|
Nanjing Shenghang Shipping Co Ltd
SHE:001205
|
0.034x |
|
Moso Power Supply Technology Co Ltd
SHE:002660
|
0.069x |
|
Zhongyan Technology Co Ltd
SHE:003001
|
0.050x |
|
Selectirente
PA:SELER
|
0.019x |
|
Tatung System Technologies
TWO:8099
|
-0.035x |
Annual Cash Flow Conversion Efficiency for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (2018–2024)
The table below shows the annual cash flow conversion efficiency of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS from 2018 to 2024. Also see total assets of Gen Ilac ve Saglik Urunleri Sanayi ve Ti for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | TL7.31 Billion ≈ $163.67 Million |
TL1.99 Billion ≈ $44.65 Million |
0.273x | +647.34% |
| 2023-12-31 | TL7.01 Billion ≈ $157.11 Million |
TL256.05 Million ≈ $5.73 Million |
0.037x | +533.85% |
| 2022-12-31 | TL2.80 Billion ≈ $62.81 Million |
TL16.15 Million ≈ $361.73K |
0.006x | -95.34% |
| 2021-12-31 | TL1.28 Billion ≈ $28.76 Million |
TL158.83 Million ≈ $3.56 Million |
0.124x | -30.18% |
| 2020-12-31 | TL557.36 Million ≈ $12.48 Million |
TL98.74 Million ≈ $2.21 Million |
0.177x | -73.86% |
| 2019-12-31 | TL245.48 Million ≈ $5.50 Million |
TL166.39 Million ≈ $3.73 Million |
0.678x | +270244.50% |
| 2018-12-31 | TL112.59 Million ≈ $2.52 Million |
TL28.23K ≈ $632.21 |
0.000x | -- |
About Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV… Read more